HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yi Qu Selected Research

integrin beta8

3/2014[Effect of integrin beta8 on neuronal apoptosis after hypoxia ischemia in astrocyte/neuron co-culture system].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yi Qu Research Topics

Disease

44Neoplasms (Cancer)
02/2022 - 02/2002
37Hypoxia (Hypoxemia)
04/2022 - 11/2007
28Ischemia
08/2020 - 03/2008
21Brain Injuries (Brain Injury)
01/2022 - 05/2010
14Inflammation (Inflammations)
02/2022 - 12/2016
13Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain)
08/2020 - 09/2008
12Carcinogenesis
05/2021 - 02/2002
12Infections
01/2021 - 05/2008
10Sepsis (Septicemia)
01/2020 - 06/2016
8Prostatic Neoplasms (Prostate Cancer)
02/2022 - 03/2007
6Hypertension (High Blood Pressure)
02/2016 - 02/2003
5Neoplasm Metastasis (Metastasis)
05/2021 - 08/2013
5Alzheimer Disease (Alzheimer's Disease)
05/2021 - 10/2011
5Macular Degeneration (Age-Related Maculopathy)
05/2019 - 01/2011
5Choroidal Neovascularization
04/2019 - 01/2009
5Diabetic Retinopathy (Retinopathy, Diabetic)
01/2016 - 01/2009
4Sepsis-Associated Encephalopathy
06/2022 - 06/2016
4Hyperbilirubinemia
02/2022 - 10/2011
4Cognitive Dysfunction
01/2022 - 01/2021
4Cardiovascular Diseases (Cardiovascular Disease)
12/2021 - 07/2015
4Macular Edema
01/2020 - 05/2013
4Type 2 Diabetes Mellitus (MODY)
01/2016 - 01/2014
3Uveitis
02/2022 - 01/2021
3Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
01/2022 - 01/2016
3Colonic Neoplasms (Colon Cancer)
01/2022 - 01/2018
3Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022 - 03/2008
3Insulin Resistance
12/2021 - 05/2015
3Body Weight (Weight, Body)
11/2021 - 07/2016
3Squamous Cell Carcinoma of Head and Neck
05/2021 - 01/2020
3Heart Failure
01/2021 - 06/2003
3Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 01/2018
3Tuberculosis (Tuberculoses)
11/2020 - 04/2011
3Bronchopulmonary Dysplasia
11/2020 - 01/2018
3Necrotizing Enterocolitis
07/2020 - 01/2018
3Brain Ischemia (Cerebral Ischemia)
01/2020 - 09/2009
3Neonatal Sepsis
12/2019 - 11/2018
3Premature Birth (Birth, Premature)
10/2019 - 12/2015
3Retinopathy of Prematurity (Retrolental Fibroplasia)
10/2019 - 01/2009
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2019 - 04/2007
3Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/2019 - 01/2017
3Brain Infarction
03/2016 - 12/2011
3Carcinoma (Carcinomatosis)
09/2008 - 03/2003
2Glaucoma
10/2022 - 03/2022
2Nervous System Diseases (Neurological Disorders)
01/2022 - 11/2014
2Liver Neoplasms (Liver Cancer)
01/2022 - 10/2003
2Cerebral Infarction
01/2022 - 12/2011
2Thrombosis (Thrombus)
12/2021 - 02/2017
2Head and Neck Neoplasms (Head and Neck Cancer)
11/2021 - 02/2017
2Trachoma
09/2021 - 01/2014

Drug/Important Bio-Agent (IBA)

35Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2008
13Oxygen (Dioxygen)IBA
08/2020 - 03/2003
12Telomerase (Telomerase Reverse Transcriptase)IBA
02/2017 - 02/2002
10Retinaldehyde (Retinal)IBA
11/2022 - 05/2009
10Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2015
10Messenger RNA (mRNA)IBA
10/2018 - 02/2003
9CateninsIBA
01/2022 - 01/2016
9salicylhydroxamic acid (SHAM)IBA
01/2020 - 11/2007
8DNA (Deoxyribonucleic Acid)IBA
12/2021 - 03/2003
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2019 - 03/2008
7Pharmaceutical PreparationsIBA
01/2022 - 04/2007
7Biological ProductsIBA
08/2020 - 07/2009
6Caspase 3 (Caspase-3)IBA
01/2022 - 11/2008
6Transcription Factors (Transcription Factor)IBA
11/2019 - 03/2008
6MicroRNAs (MicroRNA)IBA
10/2019 - 01/2009
5Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2022 - 10/2016
5EnzymesIBA
12/2021 - 01/2018
5NitrogenIBA
07/2015 - 12/2007
4p38 Mitogen-Activated Protein KinasesIBA
06/2022 - 07/2019
4Long Noncoding RNAIBA
02/2022 - 12/2015
4Glucose (Dextrose)FDA LinkGeneric
12/2021 - 03/2014
4Anti-Bacterial Agents (Antibiotics)IBA
07/2020 - 04/2011
4Triamcinolone Acetonide (Azmacort)FDA LinkGeneric
01/2020 - 05/2013
4ErythropoietinFDA Link
01/2019 - 10/2011
4Complementary DNA (cDNA)IBA
09/2008 - 02/2003
3LipidsIBA
12/2021 - 01/2020
3RNA (Ribonucleic Acid)IBA
12/2021 - 01/2013
3Indicators and Reagents (Reagents)IBA
01/2021 - 02/2003
3Vitamin DFDA LinkGeneric
01/2021 - 02/2016
3Peptides (Polypeptides)IBA
01/2021 - 08/2009
3HMGB1 Protein (HMG1)IBA
01/2020 - 01/2017
3Therapeutic UsesIBA
11/2019 - 10/2017
3Hemoglobins (Hemoglobin)IBA
09/2019 - 06/2009
3ORALIT (ORS)IBA
08/2019 - 12/2015
3Histones (Histone)IBA
01/2018 - 01/2009
3Glutamic Acid (Glutamate)FDA Link
01/2016 - 02/2010
3Atrial Natriuretic Factor (ANF)IBA
08/2004 - 02/2003
2Neuroprotective AgentsIBA
01/2022 - 12/2019
2Mechanistic Target of Rapamycin Complex 1IBA
12/2021 - 01/2018
2NitratesIBA
11/2021 - 02/2020
2AutoantibodiesIBA
05/2021 - 01/2021
2Immunoglobulin G (IgG)IBA
05/2021 - 01/2021

Therapy/Procedure

27Therapeutics
03/2022 - 02/2002
10Ligation
01/2020 - 05/2010
7Drug Therapy (Chemotherapy)
01/2022 - 10/2003
5Transplantation
01/2019 - 10/2003
4Punctures
07/2019 - 06/2016
3Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2020 - 05/2018
2Gas Lasers
10/2022 - 03/2022
2Phototherapy (Light Therapy)
02/2022 - 10/2011
2Radiotherapy
11/2021 - 05/2018